Volcano (Nasdaq: VOLC; San Diego, CA), which develops precision-guided therapy tools for diagnosing and treating coronary and peripheral vascular disease, is set to acquire Sync-Rx (Netanya, Israel), which develops software applications that use automated online image processing to facilitate transcatheter cardiovascular interventions. Volcano has developed intravascular ultrasound (IVUS) products, a line of optical coherence tomography (OCT) systems and catheters, and other image-guided therapy products.
"This transaction represents a strategic step in the advancement of our multi-modality platform," said Scott Huennekens, president and CEO of Volcano. "Sync-Rx's technology will allow Volcano to better integrate and present a wide variety of data in an intuitive manner that creates more meaningful information for the physician and documentation for the hospital," added Huennekens.
"We see the technology being incorporated seamlessly into our existing multi-modality system with the ability in the future to co-register IVUS images directly on to the angiogram. Future applications for the Sync-Rx technology in other areas include co-registration of non-invasive imaging with real time intra-body physiology measurements and IVUS peripheral, forward looking IVUS, forward looking intra-cardiac (ICE), and OCT imaging."